Splicing factor gene mutations in the myelodysplastic syndromes: impact on disease phenotype and therapeutic applications.

Splicing factor gene mutations in the myelodysplastic syndromes: impact on disease phenotype and therapeutic applications.

Splicing factor gene mutations are the most frequent mutations found in patients with the myeloid malignancy myelodysplastic syndrome (MDS), suggesting that spliceosomal dysfunction plays a major role in disease pathogenesis. The aberrantly spliced target genes and deregulated cellular pathways asso...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής
Κύριοι συγγραφείς:	Pellagatti, A, Boultwood, J
Μορφή:	Journal article
Γλώσσα:	English
Έκδοση:	Elsevier 2016

Παρόμοια τεκμήρια

Splicing factor mutations in the myelodysplastic syndromes: target genes and therapeutic approaches
ανά: Armstrong, R, κ.ά.
Έκδοση: (2017)

The role of splicing factor mutations in the pathogenesis of the myelodysplastic syndromes.
ανά: Boultwood, J, κ.ά.
Έκδοση: (2014)

Identification of aberrant splicing events in myelodysplastic syndrome patients with splicing factor gene mutations
ανά: Pellagatti, A, κ.ά.
Έκδοση: (2017)

Gene expression profiling in the myelodysplastic syndromes.
ανά: Pellagatti, A, κ.ά.
Έκδοση: (2005)

Replication stress signaling is a therapeutic target in myelodysplastic syndromes with splicing factor mutations
ανά: Johanna Flach, κ.ά.
Έκδοση: (2020-09-01)

SF3B1 mutant myelodysplastic syndrome: Recent advances
ανά: Pellagatti, A, κ.ά.
Έκδοση: (2020)

Lack of splice factor and cohesin complex mutations in pediatric myelodysplastic syndrome
ανά: Julia C. Obenauer, κ.ά.
Έκδοση: (2016-12-01)

The U2AF1S34F mutation induces lineage-specific splicing alterations in myelodysplastic syndromes.
ανά: Yip, B, κ.ά.
Έκδοση: (2017)

Frequent Mutation of the Polycomb-Associated Gene ASXL1 in the Myelodysplastic Syndromes and in Acute Myeloid Leukaemia
ανά: Boultwood, J, κ.ά.
Έκδοση: (2009)

GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR GENE IN MYELODYSPLASTIC SYNDROMES - REPLY
ανά: Boultwood, J, κ.ά.
Έκδοση: (1991)

Gene expression profiling in 5q-syndrome and myelodysplastic syndromes.
ανά: Pellagatti, A, κ.ά.
Έκδοση: (2003)

Mutations in SETBP1 are recurrent in myelodysplastic syndromes and often coexist with cytogenetic markers associated with disease progression.
ανά: Fernandez-Mercado, M, κ.ά.
Έκδοση: (2013)

Mutations in SETBP1 are recurrent in myelodysplastic syndromes and often coexist with cytogenetic markers associated with disease progression
ανά: Fernandez-Mercado, M, κ.ά.
Έκδοση: (2013)

Frequent Mutation of the Polycomb-Associated Gene ASXL1 In Acute Myeloid Leukemia Secondary to Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia
ανά: Fernandez-Mercado, M, κ.ά.
Έκδοση: (2010)

Clonality in the myelodysplastic syndromes.
ανά: Boultwood, J, κ.ά.
Έκδοση: (2001)

Targeted re-sequencing analysis of 25 genes commonly mutated in myeloid disorders in del(5q) myelodysplastic syndromes.
ανά: Fernandez-Mercado, M, κ.ά.
Έκδοση: (2013)

Frequent mutation of the polycomb-associated gene ASXL1 in the myelodysplastic syndromes and in acute myeloid leukemia.
ανά: Boultwood, J, κ.ά.
Έκδοση: (2010)

The impact of spliceosome mutations in MDS
ανά: Jacqueline Boultwood, κ.ά.
Έκδοση: (2019-06-01)

Targeted re-sequencing analysis of 25 genes commonly mutated in myeloid disorders in del(5q) myelodysplastic syndromes
ανά: Marta Fernandez-Mercado, κ.ά.
Έκδοση: (2013-12-01)

A novel splicing mutation in the gene encoding the chromatin-associated factor ATRX associated with acquired hemoglobin H disease in myelodysplastic syndrome (ATMDS)
ανά: Steensma, D, κ.ά.
Έκδοση: (2004)

Gene Expression Profiling of CD34(+) Cells in Patients with Myelodysplastic Syndromes
ανά: Pellagatti, A, κ.ά.
Έκδοση: (2008)

Cryptic splicing events in the iron transporter ABCB7 and other key target genes in SF3B1 mutant myelodysplastic syndromes
ανά: Dolatshad, H, κ.ά.
Έκδοση: (2016)

Implications of TP53 allelic state for genome stability, clinical presentation and outcomes in myelodysplastic syndromes
ανά: Bernard, E, κ.ά.
Έκδοση: (2020)

High and low, but not intermediate, PRAME expression levels are poor prognostic markers in myelodysplastic syndrome at disease presentation
ανά: Liberante, F, κ.ά.
Έκδοση: (2013)

High and low, but not intermediate, PRAME expression levels are poor prognostic markers in myelodysplastic syndrome at disease presentation.
ανά: Liberante, F, κ.ά.
Έκδοση: (2013)

Molecular pathogenesis of the myelodysplastic syndromes
ανά: Boultwood, J, κ.ά.
Έκδοση: (1999)

Deregulated Gene Expression Pathways in Myelodysplastic Syndrome Hematopoietic Stem Cells
ανά: Pellagatti, A, κ.ά.
Έκδοση: (2009)

Discovering transcription and splicing networks in myelodysplastic syndromes.
ανά: Hongyan Wang, κ.ά.
Έκδοση: (2013-01-01)

Deregulated gene expression pathways in myelodysplastic syndrome hematopoietic stem cells.
ανά: Pellagatti, A, κ.ά.
Έκδοση: (2010)

Mutations in PTPN11 are rare in adult myelodysplastic syndromes and acute myeloid leukemia.
ανά: Watkins, F, κ.ά.
Έκδοση: (2004)

COMPREHENSIVE ANALYSIS OF MUTATION STATUS, GENE EXPRESSION PROFILES, BLOOD AND BONE MARROW COUNTS AND OUTCOME IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES
ανά: Pellagatti, A, κ.ά.
Έκδοση: (2014)

Telomere length in myelodysplastic syndromes.
ανά: Boultwood, J, κ.ά.
Έκδοση: (1995)

Gene expression profiling in patients with myelodysplastic syndromes, including patients with the del(5q)
ανά: Boultwood, J
Έκδοση: (2009)

Structure of the granulocyte macrophage colony-stimulating factor gene in patients with the myelodysplastic syndromes.
ανά: Boultwood, J, κ.ά.
Έκδοση: (1990)

Expression of circular RNAs in myelodysplastic neoplasms and their association with mutations in the splicing factor gene SF3B1
ανά: Iva Trsova, κ.ά.
Έκδοση: (2023-12-01)

Identification of Prognostic Markers by Gene Expression Profiling In Myelodysplastic Syndrome Hematopoietic Stem Cells
ανά: Pellagatti, A, κ.ά.
Έκδοση: (2010)

Identification of Prognostic Markers by Gene Expression Profiling In Myelodysplastic Syndrome Hematopoietic Stem Cells
ανά: Pellagatti, A, κ.ά.
Έκδοση: (2010)

Identification of Prognostic Markers by Gene Expression Profiling In Myelodysplastic Syndrome Hematopoietic Stem Cells
ανά: Pellagatti, A, κ.ά.
Έκδοση: (2010)

8 Gene expression profiling in patients with myelodysplastic syndromes, including patients with the del(5q)
ανά: Boultwood, J
Έκδοση: (2009)

Neutrophil PRV-1 gene expression in myeloproliferative, myelodysplastic and reactive blood disorders
ανά: Zhang, J, κ.ά.
Έκδοση: (2004)